tiprankstipranks
Advertisement
Advertisement

PERCF Stock Latest News

Percheron Raises $2.2m to Advance HMBD-002 Towards Phase II Trial
Company AnnouncementsPercheron Raises $2.2m to Advance HMBD-002 Towards Phase II Trial
22h ago
Percheron Sets Closing Date for Entitlement Offer to Fund Therapeutic Pipeline
PremiumCompany Announcements
Percheron Sets Closing Date for Entitlement Offer to Fund Therapeutic Pipeline
13d ago
Percheron to Showcase New HMBD-002 Cancer Data at ASCO 2026
PremiumCompany Announcements
Percheron to Showcase New HMBD-002 Cancer Data at ASCO 2026
15d ago
Percheron Therapeutics Launches Discounted Entitlement Offer, Excludes Overseas Holders
PremiumCompany Announcements
Percheron Therapeutics Launches Discounted Entitlement Offer, Excludes Overseas Holders
22d ago
Percheron Therapeutics Launches Non-Renounceable Entitlement Offer With Free-Attaching Options
PremiumCompany Announcements
Percheron Therapeutics Launches Non-Renounceable Entitlement Offer With Free-Attaching Options
22d ago
Percheron Therapeutics Launches Discounted Entitlement and Shortfall Offer
PremiumCompany AnnouncementsPercheron Therapeutics Launches Discounted Entitlement and Shortfall Offer
30d ago
Percheron Therapeutics Plans Issue of 50 Million Unquoted Options
Premium
Company Announcements
Percheron Therapeutics Plans Issue of 50 Million Unquoted Options
30d ago
Percheron Therapeutics Plans Large Pro Rata Capital Raising on ASX
Premium
Company Announcements
Percheron Therapeutics Plans Large Pro Rata Capital Raising on ASX
30d ago
Percheron Updates Timetable for $2.2m Entitlement Offer Ahead of 2026 Trials
PremiumCompany Announcements
Percheron Updates Timetable for $2.2m Entitlement Offer Ahead of 2026 Trials
30d ago
Percheron Therapeutics Launches Pro Rata Rights Offer at Discounted Issue Price
PremiumCompany Announcements
Percheron Therapeutics Launches Pro Rata Rights Offer at Discounted Issue Price
1M ago
Percheron Therapeutics Launches Discounted Entitlement Offer to Fund HMBD-002 Trial
PremiumCompany Announcements
Percheron Therapeutics Launches Discounted Entitlement Offer to Fund HMBD-002 Trial
1M ago
Percheron Therapeutics Plans Issue of 13.75 Million Unquoted Options
PremiumCompany Announcements
Percheron Therapeutics Plans Issue of 13.75 Million Unquoted Options
1M ago
Percheron Therapeutics Narrows Half-Year Loss but Sees Net Assets Per Share Fall
PremiumCompany AnnouncementsPercheron Therapeutics Narrows Half-Year Loss but Sees Net Assets Per Share Fall
2M ago
Percheron Advances HMBD-002 into Innovative Phase II After Positive Phase I Cancer Data
Premium
Company Announcements
Percheron Advances HMBD-002 into Innovative Phase II After Positive Phase I Cancer Data
3M ago
Percheron Therapeutics Director Increases On-Market Shareholding
Premium
Company Announcements
Percheron Therapeutics Director Increases On-Market Shareholding
4M ago
Percheron Therapeutics Director James Garner Increases Shareholding via On-Market Purchase
PremiumCompany Announcements
Percheron Therapeutics Director James Garner Increases Shareholding via On-Market Purchase
4M ago
Percheron Therapeutics Updates Corporate Presentation with New Program Insights
PremiumCompany Announcements
Percheron Therapeutics Updates Corporate Presentation with New Program Insights
5M ago
Percheron Therapeutics Advances HMBD-002 with Positive Trial Results
PremiumCompany Announcements
Percheron Therapeutics Advances HMBD-002 with Positive Trial Results
6M ago
Percheron Therapeutics Reports Strong Shareholder Support at AGM
PremiumCompany Announcements
Percheron Therapeutics Reports Strong Shareholder Support at AGM
6M ago
Percheron Therapeutics Unveils Future Plans at AGM
PremiumCompany AnnouncementsPercheron Therapeutics Unveils Future Plans at AGM
6M ago
Percheron Therapeutics Releases Final Results of Phase I Clinical Trial for HMBD-002
Premium
Company Announcements
Percheron Therapeutics Releases Final Results of Phase I Clinical Trial for HMBD-002
6M ago
Percheron Therapeutics Advances HMBD-002 Cancer Therapy Development
Premium
Company Announcements
Percheron Therapeutics Advances HMBD-002 Cancer Therapy Development
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >